Rhythm Pharmaceuticals buy The Goldman Sachs Group, Inc.
Start price
02.03.23
/
50%
€23.20
Target price
02.03.24
€42.45
Performance (%)
69.83%
End price
03.03.24
€39.40
Summary
This prediction ended on 03.03.24 with a price of €39.40. The BUY prediction by The_Goldman_Sachs_Gr for Rhythm Pharmaceuticals saw massive gains of 69.83%. The_Goldman_Sachs_Gr has a follow-up prediction for Rhythm Pharmaceuticals where he still thinks Rhythm Pharmaceuticals is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rhythm Pharmaceuticals | 9.581% | 9.581% | 140.789% |
| iShares Core DAX® | 0.597% | 3.083% | 16.090% |
| iShares Nasdaq 100 | 0.899% | 5.338% | 29.239% |
| iShares Nikkei 225® | 1.775% | -1.206% | 6.823% |
| iShares S&P 500 | 0.990% | 3.500% | 24.956% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $40.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
In the thread Trading Rhythm Pharmaceuticals
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by The_Goldman_Sachs_Gr for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€35.40
07.12.23
07.12.23
€38.96
07.12.24
07.12.24
3.39%
04.06.24
04.06.24
Stopped prediction by The_Goldman_Sachs_Gr for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€40.80
25.01.24
25.01.24
€47.88
25.01.25
25.01.25
-10.29%
04.06.24
04.06.24